☆ 4.8 Article

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters

Rana Abdelnabi et al.

Summary: The infectivity of the omicron variant in hamsters was found to be lower than that of the ancestral D614G strain, with a significant decrease in viral RNA load in the lungs and no detectable infectious virus in this organ. Histopathological examination of the lungs from omicron-infected hamsters revealed no signs of peri-bronchial inflammation or bronchopneumonia.

ANTIVIRAL RESEARCH (2022)

添加到收藏夹

Article Immunology

A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection

Patricia Perez et al.

Summary: Researchers developed an optimized COVID-19 vaccine candidate using a modified vaccinia virus Ankara vector, which expressed a full-length prefusion-stabilized SARS-CoV-2 spike protein. The vaccine showed enhanced immunogenicity and efficacy against SARS-CoV-2 in animal models, making it a promising candidate for clinical trials.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice

Adrian Lazaro-Frias et al.

Summary: The MVA-CoV2-S vaccine candidate protected transgenic mice from a lethal dose of SARS-CoV-2 through two doses, inducing high levels of antibodies and providing long-term memory immune responses. The vaccine showed efficacy in preventing virus replication, reducing lung pathology, and inducing protective antibody responses against the parental virus and variants of concern.

NPJ VACCINES (2022)

添加到收藏夹

Article Virology

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice

Juan Garcia-Arriaza et al.

Summary: Two COVID-19 vaccines based on MVA vectors induced robust and polyfunctional T-cell responses and neutralizing antibody titers in mice, providing protection against SARS-CoV-2. The results demonstrate the full efficacy of MVA-based COVID-19 vaccines in animal models and support their translation to clinical use.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sanchez-Felipe et al.

Summary: The candidate vaccine YF-S0, utilizing the YF17D vaccine as a vector to express noncleavable prefusion form of the SARS-CoV-2 spike antigen, showed excellent safety, immunogenicity, and efficacy in animal models. It induced high levels of neutralizing antibodies, provided protective immunity against SARS-CoV-2, and prevented infection in hamsters and macaques. A single dose was able to confer protection from lung disease in most vaccinated hamsters within 10 days, highlighting the potential of YF-S0 as a potent SARS-CoV-2 vaccine candidate.

NATURE (2021)

添加到收藏夹

Article Cell Biology

Vaccine-induced immune thrombosis and thrombocytopenia syndrome following adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms and implications for future vaccine development

Paul Monagle et al.

Summary: The hypothesis suggests that thrombosis with thrombocytopenia syndrome observed after administration of adenovirus-vectored vaccines for SARS-CoV-2 may be due to the antigen being delivered to cells of the immune system, leading to platelet decrease and blood clot formation. This hypothesis is testable through cell culture, animal models, and potentially in vivo, with significant implications for vaccine development and the understanding of the relationship between the coagulation and immune systems.

IMMUNOLOGY AND CELL BIOLOGY (2021)

添加到收藏夹

Article Immunology

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu et al.

Summary: The study demonstrates that MVA/S vaccination induces strong neutralizing antibody and T cell responses, providing protection against SARS-CoV-2 in mice and macaques. Single-cell RNA sequencing analysis of lung cells reveals that the vaccination also protects macaques from infection-induced inflammation and B cell abnormalities.

IMMUNITY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection

Ruikang Liu et al.

Summary: Research on modified vaccinia virus Ankara (MVA) expressing the S protein of SARS-CoV-2 showed promising results in inducing antibodies and CD8+ T cells, protecting transgenic mice from lethal infection, preventing nasal infection, reducing cytokine expression, and effectively terminating virus replication in vaccinated animals.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS-CoV-2 vaccine candidates in the Syrian hamster model

Sreelekshmy Mohandas et al.

Summary: The study demonstrated that the BBV152A and BBV152B vaccine candidates induced quick and robust immune responses, providing protection to Syrian hamsters from lung pathology after SARS-CoV-2 infection.

ISCIENCE (2021)

添加到收藏夹

Article Immunology

Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents

Berislav Bosnjak et al.

Summary: The study demonstrates that intranasal delivery of MVA-SARS-2-S effectively induces pulmonary spike-specific CD8(+) T cells, albeit with restricted production of neutralizing antibodies. Intranasal booster vaccine delivery is crucial for massive expansion of spike-specific CD8(+) T cells in systemic and lung tissues, as well as the development of Th1 - but not Th2 - CD4(+) T cells, with high levels of IgG and IgA anti-spike antibodies capable of neutralizing all current SARS-CoV-2 variants of concern.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome

Alexander T. Baker et al.

Summary: Vaccines using chimpanzee adenovirus, human adenovirus, and other types have played a crucial role in the pandemic but may induce rare side effects. Research shows these vaccines may bind with PF4, affecting the mechanism of HIT.

SCIENCE ADVANCES (2021)

添加到收藏夹

Article Immunology

MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challenge

Clement A. Meseda et al.

Summary: Using MVA vectors expressing SARS-CoV-2 S as vaccines provides protection in adult Syrian hamsters, demonstrating the utility of this animal model in evaluating candidate SARS-CoV-2 vaccines.

NPJ VACCINES (2021)

添加到收藏夹

Article Medicine, General & Internal

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data

Robert H Shaw et al.

LANCET (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Letter Medicine, General & Internal

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications

Salim S. Abdool Karim et al.

Summary: The emergence of SARS-CoV-2 variants, including B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351), and P.1 (B.1.1.28.1), has raised concerns about worsening Covid-19 and potential escape from vaccine-induced immunity.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Editorial Material Critical Care Medicine

COVID-19 and the intensive care unit: vaccines to the rescue

Kai Dallmeier et al.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Variants of SARS-CoV-2

Adam S. Lauring et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Virology

A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters

Mijia Lu et al.

Summary: The study developed a recombinant vesicular stomatitis virus (mtdVSV)-based SARS-CoV-2 vaccine candidate, which was proven to be safe and highly efficacious in mouse and hamster experiments. It induced high levels of neutralizing antibodies and showed promise in providing protection against SARS-CoV-2 infection.

JOURNAL OF VIROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters

Rakesh Kulkarni et al.

Summary: SARS-CoV-2 causes severe illness and mortality, highlighting the urgent need for vaccines. The development of stable lyophilized vaccines is crucial for global vaccination to combat the virus and potential variants. Additionally, promising candidate vaccines based on viral strains have shown to induce strong immune responses in animal models, providing hope for future development.

PLOS ONE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination

Alina Tscherne et al.

Summary: The SARS-CoV-2 virus has caused the COVID-19 pandemic, and a recombinant MVA expressing the SARS-CoV-2 spike protein shows promise as a candidate for developing a COVID-19 vaccine.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Cell Biology

Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern

Lisa H. Tostanoski et al.

Summary: This study explored how mutations in spike proteins of different SARS-CoV-2 variants affect natural and vaccine-induced immunity, finding that primary infection with the WA1/2020 strain provided strong protection, while antibodies induced by the Ad26.COV2.S vaccine showed reduced neutralizing activity against the B.1.351 strain but still offered effective protection.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters

Rana Abdelnabi et al.

Summary: The global COVID-19 pandemic has resulted in over 108 million infections and 2.4 million deaths within a year, with new variants of concern emerging. Research on prototypic VoC from B.1.1.7 and B.1.351 variants in hamsters revealed efficient infection of the lower respiratory tract and highlighted the need for assessing vaccine and therapeutic efficacy against these variants.

EBIOMEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Article Immunology

Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility

Jasper Fuk-Woo Chan et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Virology

Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples

Alessandro Manenti et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

添加到收藏夹

Article Microbiology

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies

Niraj Mishra et al.

MBIO (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Immunology

Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins

Jose Maria Diez et al.

IMMUNOTHERAPY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Robbert Boudewijns et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus

Melanie Thompson et al.

PLOS ONE (2016)

添加到收藏夹

Review Immunology

Clinical applications of attenuated MVA poxvirus strain

Carmen Elena Gomez et al.

EXPERT REVIEW OF VACCINES (2013)

添加到收藏夹

Article Immunology

Clinical development of Modified Vaccinia virus Ankara vaccines

Sarah C. Gilbert

VACCINE (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Viral Cross-Class Serpin Inhibits Vascular Inflammation and T Lymphocyte Fratricide; A Study in Rodent Models In Vivo and Human Cell Lines In Vitro

Kasinath Viswanathan et al.

PLOS ONE (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

Max Corbett et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice

Carmen Elena Gomez et al.

JOURNAL OF GENERAL VIROLOGY (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.